(VIANEWS) – MERCIALYS (MERY.PA), HEINEKEN HOLDING (HEIO.AS), SARTORIUS STED BIO (DIM.PA) are the highest payout ratio stocks on this list.
Here’s the data we’ve collected of stocks with a high payout ratio at the moment. The payout ratio in itself isn’t a promise of a future good investment but it’s an indicator of whether dividends are being paid and how the company chooses to distribute them.
When researching a potential investment, the dividend payout ratio is a good statistic to know so here is a list of some companies with an above 30% payout ratio.
1. MERCIALYS (MERY.PA)
168.42% Payout Ratio
Mercialys is one of France's leading real estate companies. It is specialized in the holding, management and transformation of retail spaces, anticipating consumer trends, on its own behalf and for third parties. At December 31, 2023, Mercialys had a real estate portfolio valued at Euro 2.9 billion (including transfer taxes). Its portfolio of 2,038 leases represents an annualized rental base of Euro 175.5 million. Mercialys has been listed on the stock market since October 12, 2005 (ticker: MERY) and has “SIIC” real estate investment trust (REIT) tax status. Part of the SBF 120 and Euronext Paris Compartment B, it had 93,886,501 shares outstanding at December 31, 2023.
Earnings Per Share
As for profitability, MERCIALYS has a trailing twelve months EPS of €0.57.
PE Ratio
MERCIALYS has a trailing twelve months price to earnings ratio of 18.09. Meaning, the purchaser of the share is investing €18.09 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.2%.
More news about MERCIALYS.
2. HEINEKEN HOLDING (HEIO.AS)
46.6% Payout Ratio
Heineken Holding N.V., through its subsidiaries, engages in brewing and selling beer and cider in the Netherlands and internationally. The company's portfolio consists of approximately 300 international, regional, local, and specialty beers and ciders. The company was founded in 1864 and is based in Amsterdam, the Netherlands. Heineken Holding N.V. is a subsidiary of L'Arche Green N.V.
Earnings Per Share
As for profitability, HEINEKEN HOLDING has a trailing twelve months EPS of €4.12.
PE Ratio
HEINEKEN HOLDING has a trailing twelve months price to earnings ratio of 17.33. Meaning, the purchaser of the share is investing €17.33 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.84%.
Volume
Today’s last reported volume for HEINEKEN HOLDING is 31416 which is 64.87% below its average volume of 89435.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Apr 29, 2024, the estimated forward annual dividend rate is 2.08 and the estimated forward annual dividend yield is 2.93%.
Yearly Top and Bottom Value
HEINEKEN HOLDING’s stock is valued at €71.40 at 11:10 EST, way below its 52-week high of €88.85 and above its 52-week low of €69.50.
More news about HEINEKEN HOLDING.
3. SARTORIUS STED BIO (DIM.PA)
42.86% Payout Ratio
Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, separation, purification, and fluid management services; biolayer interferometry instruments; microbiology enumeration, sterility testing, and air monitoring instruments; pipette products; sensors and analyzers; biomolecule analysis tools; flow cytometry; batch and intensified chromatography systems; lab data and fleet management software; live cell imaging and analysis; surface plasmon resonance solutions; and weighing products. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production; process automation platform and software; and develops and produces transfection, as well as other DNA/RNA delivery reagents and plasmid DNA. It serves manufacturers of medications, vaccines, foods, and chemicals, as well as research and development laboratories. The company was incorporated in 1978 and is headquartered in Aubagne, France. As of December 31, 2023, Sartorius Stedim Biotech S.A. operates as a subsidiary of Sartorius AG.
Earnings Per Share
As for profitability, SARTORIUS STED BIO has a trailing twelve months EPS of €3.37.
PE Ratio
SARTORIUS STED BIO has a trailing twelve months price to earnings ratio of 81.39. Meaning, the purchaser of the share is investing €81.39 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.03%.
Moving Average
SARTORIUS STED BIO’s value is way higher than its 50-day moving average of €246.31 and way above its 200-day moving average of €234.02.
More news about SARTORIUS STED BIO.
4. EIFFAGE (FGR.PA)
33.8% Payout Ratio
Eiffage SA engages in the construction, property development, urban development, civil engineering, metallic construction, roads, energy systems, and concessions businesses in France and internationally. The company operates through Construction, Infrastructure, Energy Systems, Concessions, and Holding Company segments. The Construction segment offers urban development, building design and construction, property development, and maintenance and facilities management services. The Infrastructure segment is involved in undertaking civil engineering, road and rail design and construction, drainage, earthworks, and metallic construction. The Energy Systems segment designs, constructs, integrates, operates, and maintains energy and telecommunication systems and equipment. The Concessions segment constructs and manages concession contracts and public-private partnerships. The company was founded in 1844 and is based in Vélizy-Villacoublay, France.
Earnings Per Share
As for profitability, EIFFAGE has a trailing twelve months EPS of €10.65.
PE Ratio
EIFFAGE has a trailing twelve months price to earnings ratio of 9.72. Meaning, the purchaser of the share is investing €9.72 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.94%.
More news about EIFFAGE.
1. 1 (1)
1% Payout Ratio
1
Earnings Per Share
As for profitability, 1 has a trailing twelve months EPS of €1.
PE Ratio
1 has a trailing twelve months price to earnings ratio of 1. Meaning, the purchaser of the share is investing €1 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 1%, now sitting on 1 for the twelve trailing months.
Earnings Before Interest, Taxes, Depreciation, and Amortization
1’s EBITDA is 1.
More news about 1.
